-
ASCO-GU Interview | Dr. Shun Zhang: The Value and Development of Genetic Testing in Precision Treatment of Prostate Cancer
Oncology Frontier: The research presented at this ASCO-GU prostate cancer session highlights the increasing importance of genetic testing in prostate cancer, guided by molecular typing for precision targeted therapy. Based…
-
2024 CASH | Professor Tao Cheng: Misaligned Development, Collaborative Innovation – A Discussion on High-Quality Development in Hematology Against the Backdrop of the Innovation Era
The Fourth China Hematology Development Conference was held in Tianjin from January 5th to 7th, 2024. Themed “Broadening Hematology, Healthcare, and Wellness,” the conference focused on the core development directions of the hematology discipline and engaged in discussions and sharing of hot topics and cutting-edge issues in basic hematology research, translation, and clinical diagnosis and…
-
ASCO-GU Interview | Dr. Qiang Wei: Embracing the Era of Precision Treatment, Offering Personalized Treatment Through Multidisciplinary Management
Editor’s Note: Prostate cancer is the most common “silent killer” threatening men’s health worldwide, with traditional treatments primarily involving surgery, radiation therapy, chemotherapy, and hormonal therapy. In recent years, the…
-
ASCO-GU Interview | Dr. Junlong Zhuang Interprets the BRCAAway Study and Real-World Genetic Testing in Advanced Prostate Cancer
Oncology Frontier: BRCA mutations are the most clinically significant type of mutation in prostate cancer. At this ASCO-GU, we saw the presentation of treatment efficacy results from the BRCAAway study,…
-
Website Disclaimer
Content marked as original on the “Infectious Disease Frontier” platform holds copyright under Infectious Disease Frontier. While we encourage sharing and reproduction of our content, it must be done with prior written consent from Infectious Disease Frontier. Unauthorized use is strictly prohibited, and legal action may be taken against infringement.
-
The Role of Fanconi Anemia Signaling Pathway Genes in Myelodysplastic Syndromes and Acute Myeloid Leukemia: Insights from Mutation Spectrum, Expression Profiling, and Prognosis Evaluation
In November 2023, a study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal ——BMC Med Genomics. The title of the study is “Mutation spectrum, expression profiling, and prognosis evaluation of Fanconi anemia signaling pathway…
-
Pediatric Acute Myeloid Leukemia and Hyperleukocytosis: Prognostic Impact of High White Blood Cell Counts
In November 2023, a study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal ——Current Opinion In Pediatrics. The title of the study is “Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy”. The study represents…
-
Iron Chelation Therapy in Myelodysplastic Syndrome Mice: A Study on Erythropoiesis and Iron Overload
In December 2023, a study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal——Elife. The title of the study is “Iron chelation improves ineffective erythropoiesis and iron overload in myelodysplastic syndrome mice”. The study provides…
Connecting Medical Expertise through Media